About This Site
Cavernous Angioma Information
Genetics of Cavernous Angioma
Questions to Ask Your Doctor
glossary
Community Forum Instructions
Community Forum
Chat Information
List Server Information
Your Stories
Support Contacts
Newsletter
Family Conference
press room
Research Funding
Genetic Non-discrimination
Genetic Testing
Diagnostic Imaging
Brainstem Cavernous Angioma
Hemorrhage
Radiosurgery
Spinal Cavernous Angioma
Temporal Lobe Epilepsy
Venous Angioma
Preparing for Surgery
Things for the Hospital
Caregiver Information
Emotional Support
Rehabilitation
Cognitive Changes
Vocational Rehabilitation
Pregnancy & cavernous angioma
Children with cavernous angioma
Cavernous Angioma and School
Patient Tissue/DNA Bank & Registry
US Studies
International Studies
General Resources
Disability Resources
Financial/Insurance Resources
About Angioma Alliance
Mission and Vision
Board of Directors
Scientific Advisory Board
Volunteer Opportunities
Financial Statements
Angioma Alliance Product Store
IGive
Bookstore
Make a Donation
Genetic Testing
Clinical Testing for Genetic Mutations

There are two types of testing for genetic mutations: research and clinical. Because of its strict regulation, clinical testing can be used to make a diagnosis of a genetic mutation. Research testing (that which you get when you enroll in a study) must be verified by a clinical test before it is considered to be a formal diagnosis.

At this time, there is only one laboratory in the USA that is approved to perform clinical testing of the CCM1, CCM2, and CCM3 genes. This is Prevention Genetics, a for-profit laboratory. The information below describes the tests that are offered and the costs involved as of the time of this posting. The information that your doctor or genetic counselor will need to begin the testing process can be found on the Clinical DNA Testing Services page of the Prevention Genetics website. The site provides the specimen and shipping requirements as well as the CPT codes that can be used to bill insurance. Many insurance carriers will cover diagnostic genetic testing. Prevention Genetics does not offer prenatal testing.

Before beginning clinical genetic testing, there are several things to know. First, genetic testing by sequencing the gene can only rule in a mutation; it can not rule out one. This means that a negative result does not necessarily mean that a genetic mutation does not exist. There are two reasons for this. First, this is because there are ways that a gene can mutate that are not picked up by sequencing – follow up testing would be performed if this were suspected. Second, a small portion of the CCM2 gene has not been reliably sequenced, so a mutation on this gene may be missed.

Another more obvious caution is that it appears that not all of the genes that can cause hereditary CCM have been discovered at this time.

That said, if you choose to have genetic testing and a genetic mutation is identified, this can make it very affordable for your family to be screened for the mutation. Rather than going through an MRI, other family members can submit blood, or in some cases simple cheek swabs, for “CCM Known Mutation Detection” or “KRIT1 Common Hispanic Mutation Detection” sequencing.

Genetic testing can yield potentially upsetting results. Please make certain that you have the necessary support –a genetic counselor or a very knowledgeable and compassionate doctor – before beginning this process.

Prevention Genetics Testing Available

Note: Only 1 blood sample is required to run all tests.

For additional information about each test, see the Clinical DNA Testing Services page of the Prevention Genetics website.

Cerebral Cavernous Malformation 1 (CCM1) KRIT1 exon 10 “Common Hispanic” Mutation Detection.
The identical KRIT1 mutation is common to many Hispanic families affected with CCMs.

Cost KRIT1/CCM1 “Common Hispanic” Mutation Test by Sequencing KRIT1 exon 10 $210.00


Cerebral Cavernous Malformation 1 (CCM1) KRIT1 Mutation Detection by Sequencing.
Other CCM1 kindreds harbor other mutations in other exons of the KRIT1 gene. Identification of these other mutations has potential clinical significance for presymptomatic diagnosis of CCM in this population and their families.

Cost KRIT1/CCM1 Mutation Test by Sequencing the 16 KRIT1 gene exons $1,410.00


Cerebral Cavernous Malformation 2 (CCM2) MGC4607 Mutation Detection by Sequencing.
In families where no KRIT1/CCM1 mutations are shown, CCM2 testing is available.

Cost MGC4607/CCM2 Mutation Test by Sequencing the 10 MGC4607 gene exons $980.00


Cerebral Cavernous Malformation 3 (CCM3) PDCD10 Mutation Detection by Sequencing.
A clinical test for this newest CCM3 gene is now available.

Cost PDCD10/CCM3 Mutation Test by Sequencing 7 PDCD10 gene exons $725.00


Cerebral Cavernous Malformation CCM Known Gene Mutation Detection by Sequencing.
In patients where a specific mutation has been demonstrated in a family member, testing will focus on sequencing the exon where the known mutation has been observed.

Cost CCM Known Mutation Test by Specific Exon Sequencing $210.00


Accreditation Info. CLIA ID #: 52D1027685 (expires 1/18/07) (CAP#: 7185561, AU ID: 1407125 expires 12/20/06)

Ship to:

Attn: Diagnostics Lab
PreventionGenetics LLC
3700 Downwind Drive
Marshfield, WI 54449 USA

Contact for information:

Dr. Eric W. Johnson
Lab Director, Molecular Diagnostics and BioBanking
eric.johnson@preventiongenetics.com
Contact: 715-387-0484
FAX: 715-384-3661